Update Membership Claim dcbtnnext dcbtnPrevious dcbtnnext_h dcbtnPrevious_h L_ pmarker dcwatermark

Professional Statement

  • Dr. Klafter is Board Certified in Hematology and Medical Oncology. New York Magazine included him in their 2012 list of New York's Best Doctors. After college at The University of Pennsylvania, he went to medical school at New York University, graduating in 1994. He completed residency and was a Chief Resident at Bellevue Hospital/NYU. After fellowship at Emory University, he returned to New York in 2001.
  • Dr. Klafter is an attending physician at Mount Sinai Medical Center and Lenox Hill Hospital. He holds an appointment as Assistant Clinical Professor at the Mount Sinai School of Medicine. Active in the teaching of medical students, residents and fellows, he has been awarded the Leslie Kuhn Memorial Award for Service to the Department of Medicine.
  • Dr. Klafter specializes in the close care of his patients. Always available and invested in the best outcomes, he seeks to provide intimate, personalized care. This remains the hallmark of his practice.
  • He is active in the American Society of Clinical Oncology, American Society of Hematology and NY State Medical Society. Listed in America's Top Oncologists, Best Doctors and New York Super Doctors, he looks to give every patient the best possible care required in their time of illness.
  • His greatest accomplishments are his two boys.

Education & Training

  • Medical School - New York University
  • Emory University Hospital, Fellowship in Hematology
  • Emory University Hospital, Fellowship in Oncology
  • New York University Medical Center, Residency in Internal Medicine

Board Certifications

  • Hematology (Internal Medicine)
  • Medical Oncology (Internal Medicine)

Awards and Publications

  • New York Super Doctors
  • Best Doctors
  • America's Top Oncologists
  • Perioperative Care in Adult Cardiac Surgery, In Filsoufi, Adams (eds)
  • Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(Ink4a) and activation of MAP kinase. Mol Med.2002 Jan;8(1):1-8. PMID: 11984000
  • Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci U S A 2002 Jan 22;99(2):715-20 PMID 11805326
  • Hypoxia-inducible factor 1 as a novel diagnostic and their therapeutic target in human cancers. Recent Res. Devel. Cancer,3(2001):49-68
  • Regulations of angiogenesis and tumorigensis by signal Transduction cascades: lessons from benign and malignant endothelial tumors. J investing Dermatol Symp Proc. 2000 Dec;5(1):79-82 Review. PMID: 11147680
  • Genetic and Signal Transduction Analysis of a Nickel Sulfide-Induced Sarcoma.

Professional Memberships

  • American Society of Hematology
  • American Society of Clinical Oncology
  • Medical Society of the State of New York

Language Spoken

  • English
  • Spanish